Liver Diseases  >>  Roferon A (recombinant interferon alfa-2a)  >>  Phase 4
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Roferon A (recombinant interferon alfa-2a) / Roche
NCT00207311: Study for the Treatment of Significant Steatosis With Xenical Followed by Treatment of Hepatitis C With Pegasys/Copegus

Completed
4
30
US
Xenical, Pegasys, Copegus, Xenical (orlistat), Pegasys (PEG-Interferon alpha-2a), Xenicare Program, Xenical placebo, Pegasys (Peg interferon alpha-2a)
Brooke Army Medical Center, Hoffmann-La Roche, The Geneva Foundation
Fatty Liver, Hepatitis C
05/09
05/09

Download Options